JOHN F MILLIGAN Insider Trading Transactions
Get free email notifications about insider trading for JOHN F MILLIGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN F MILLIGAN. JOHN F MILLIGAN is COO in GILEAD SCIENCES INC ($GILD) and COO and CFO in GILEAD SCIENCES INC ($GILD) and EVP, Chief Financial Officer in GILEAD SCIENCES INC ($GILD) and EVP, COO and CFO in GILEAD SCIENCES INC ($GILD) and President and CEO in GILEAD SCIENCES INC ($GILD) and President and COO in GILEAD SCIENCES INC ($GILD) and President, COO and Director in GILEAD SCIENCES INC ($GILD) and Director in PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ($PACB) and Director in 4D Molecular Therapeutics Inc. ($FDMT).
Latest Insider Trading Transactions of JOHN F MILLIGAN
Sentiment: All, FDMT, GILD, PACB
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.41 | 100 | 5,441 | 115,721 | 115.8 K to 115.7 K (-0.09 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.42 | 200 | 10,884 | 115,821 | 116 K to 115.8 K (-0.17 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.44 | 500 | 27,220 | 116,021 | 116.5 K to 116 K (-0.43 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.45 | 600 | 32,670 | 116,521 | 117.1 K to 116.5 K (-0.51 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.46 | 200 | 10,892 | 117,121 | 117.3 K to 117.1 K (-0.17 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.48 | 400 | 21,792 | 117,321 | 117.7 K to 117.3 K (-0.34 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.50 | 700 | 38,150 | 117,721 | 118.4 K to 117.7 K (-0.59 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.51 | 600 | 32,706 | 118,421 | 119 K to 118.4 K (-0.50 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | P | 54.53 | 400 | 21,812 | 119,021 | 119.4 K to 119 K (-0.33 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.54 | 300 | 16,362 | 119,421 | 119.7 K to 119.4 K (-0.25 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.55 | 600 | 32,730 | 119,721 | 120.3 K to 119.7 K (-0.50 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.56 | 2,200 | 120,032 | 120,321 | 122.5 K to 120.3 K (-1.80 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.59 | 500 | 27,295 | 122,521 | 123 K to 122.5 K (-0.41 %) |
Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 30,000 | 352,737 | 123,021 | 93 K to 123 K (+32.25 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 29,320 | 344,742 | 77,824 | |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.41 | 680 | 5,036 | 0 | |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 44.01 | 400 | 17,604 | 93,021 | 93.4 K to 93 K (-0.43 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 44.00 | 6,000 | 264,000 | 93,421 | 99.4 K to 93.4 K (-6.03 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 43.99 | 500 | 21,995 | 99,421 | 99.9 K to 99.4 K (-0.50 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 43.99 | 12,000 | 527,880 | 99,921 | 111.9 K to 99.9 K (-10.72 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 43.98 | 5,900 | 259,482 | 111,921 | 117.8 K to 111.9 K (-5.01 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 43.97 | 4,520 | 198,744 | 117,821 | 122.3 K to 117.8 K (-3.69 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 43.97 | 680 | 29,900 | 122,341 | 123 K to 122.3 K (-0.55 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 29,320 | 344,742 | 123,021 | 93.7 K to 123 K (+31.29 %) |
Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.41 | 680 | 5,036 | 93,701 | 93 K to 93.7 K (+0.73 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 30,000 | 352,737 | 107,144 | |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.22 | 13,700 | 496,214 | 92,302 | 106 K to 92.3 K (-12.92 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.23 | 800 | 28,984 | 106,002 | 106.8 K to 106 K (-0.75 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.24 | 500 | 18,120 | 106,802 | 107.3 K to 106.8 K (-0.47 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.25 | 200 | 7,250 | 107,302 | 107.5 K to 107.3 K (-0.19 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.26 | 2,600 | 94,276 | 107,502 | 110.1 K to 107.5 K (-2.36 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.27 | 600 | 21,762 | 110,102 | 110.7 K to 110.1 K (-0.54 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.28 | 500 | 18,140 | 110,702 | 111.2 K to 110.7 K (-0.45 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.29 | 1,300 | 47,177 | 111,202 | 112.5 K to 111.2 K (-1.16 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.30 | 1,000 | 36,300 | 112,502 | 113.5 K to 112.5 K (-0.88 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 36.31 | 8,800 | 319,528 | 113,502 | 122.3 K to 113.5 K (-7.20 %) |
May 02 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 30,000 | 352,737 | 122,302 | 92.3 K to 122.3 K (+32.50 %) |
Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 20,000 | 235,158 | 137,144 | |
Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 35.29 | 7,500 | 264,675 | 92,302 | 99.8 K to 92.3 K (-7.51 %) |
Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 35.28 | 12,500 | 441,000 | 99,802 | 112.3 K to 99.8 K (-11.13 %) |
Feb 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 20,000 | 235,158 | 112,302 | 92.3 K to 112.3 K (+21.67 %) |
Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 32.02 | 171,877 | 5,503,502 | 171,877 | |
Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.30 | 4,000 | 29,188 | 4,000 | |
Dec 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.30 | 4,000 | 29,188 | 92,302 | 88.3 K to 92.3 K (+4.53 %) |
Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.41 | 22,000 | 162,939 | 680 | |
Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 34.51 | 500 | 17,255 | 89,596 | 90.1 K to 89.6 K (-0.55 %) |
Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 34.50 | 21,500 | 741,750 | 90,096 | 111.6 K to 90.1 K (-19.27 %) |
Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.41 | 22,000 | 162,939 | 111,596 | 89.6 K to 111.6 K (+24.55 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,780 | 115,241 | 11,340 | |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.16 | 220 | 3,114 | 0 | |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 7,780 | 494,030 | 44,081 | 51.9 K to 44.1 K (-15.00 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,780 | 115,241 | 51,861 | 44.1 K to 51.9 K (+17.65 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 220 | 13,970 | 44,081 | 44.3 K to 44.1 K (-0.50 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.16 | 220 | 3,114 | 44,301 | 44.1 K to 44.3 K (+0.50 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,780 | 115,241 | 11,340 | |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.16 | 220 | 3,114 | 0 | |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 7,780 | 494,030 | 44,081 | 51.9 K to 44.1 K (-15.00 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,780 | 115,241 | 51,861 | 44.1 K to 51.9 K (+17.65 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 220 | 13,970 | 44,081 | 44.3 K to 44.1 K (-0.50 %) |
Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.16 | 220 | 3,114 | 44,301 | 44.1 K to 44.3 K (+0.50 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 8,000 | 118,500 | 19,120 | |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.16 | 200 | 12,032 | 44,081 | 44.3 K to 44.1 K (-0.45 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.30 | 800 | 48,240 | 44,281 | 45.1 K to 44.3 K (-1.77 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.36 | 500 | 30,180 | 45,081 | 45.6 K to 45.1 K (-1.10 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.31 | 600 | 36,186 | 45,581 | 46.2 K to 45.6 K (-1.30 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.37 | 200 | 12,074 | 46,181 | 46.4 K to 46.2 K (-0.43 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.29 | 200 | 12,058 | 46,381 | 46.6 K to 46.4 K (-0.43 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.28 | 100 | 6,028 | 46,581 | 46.7 K to 46.6 K (-0.21 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.25 | 500 | 30,125 | 46,681 | 47.2 K to 46.7 K (-1.06 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.24 | 400 | 24,096 | 47,181 | 47.6 K to 47.2 K (-0.84 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.23 | 300 | 18,069 | 47,581 | 47.9 K to 47.6 K (-0.63 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.22 | 300 | 18,066 | 47,881 | 48.2 K to 47.9 K (-0.62 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.21 | 200 | 12,042 | 48,181 | 48.4 K to 48.2 K (-0.41 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.17 | 200 | 12,034 | 48,381 | 48.6 K to 48.4 K (-0.41 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.15 | 100 | 6,015 | 48,581 | 48.7 K to 48.6 K (-0.21 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.12 | 100 | 6,012 | 48,681 | 48.8 K to 48.7 K (-0.20 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.11 | 2,700 | 162,297 | 48,781 | 51.5 K to 48.8 K (-5.24 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.38 | 100 | 6,038 | 51,481 | 51.6 K to 51.5 K (-0.19 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.44 | 500 | 30,220 | 51,581 | 52.1 K to 51.6 K (-0.96 %) |
May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 8,000 | 118,500 | 52,081 | 44.1 K to 52.1 K (+18.15 %) |
Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,000 | 103,688 | 27,120 | |
Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.95 | 700 | 39,865 | 44,081 | 44.8 K to 44.1 K (-1.56 %) |
Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.90 | 500 | 28,450 | 44,781 | 45.3 K to 44.8 K (-1.10 %) |
Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.89 | 5,800 | 329,962 | 45,281 | 51.1 K to 45.3 K (-11.35 %) |
Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,000 | 103,688 | 51,081 | 44.1 K to 51.1 K (+15.88 %) |
Jan 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 61.06 | 148,363 | 9,059,045 | 148,363 | |
Jan 30 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 61.06 | 1,637 | 99,955 | 1,637 |